nodes	percent_of_prediction	percent_of_DWPC	metapath
Desonide—Application site rash—Estradiol—osteoporosis	0.0282	0.0292	CcSEcCtD
Desonide—Application site erythema—Estradiol—osteoporosis	0.0261	0.0271	CcSEcCtD
Desonide—Stinging—Calcium Acetate—osteoporosis	0.0253	0.0262	CcSEcCtD
Desonide—Application site irritation—Estradiol—osteoporosis	0.0222	0.023	CcSEcCtD
Desonide—Induration—Pamidronate—osteoporosis	0.0196	0.0203	CcSEcCtD
Desonide—Induration—Zoledronate—osteoporosis	0.0179	0.0185	CcSEcCtD
Desonide—Allergic contact dermatitis—Estradiol—osteoporosis	0.0176	0.0183	CcSEcCtD
Desonide—Swelling face—Conjugated Estrogens—osteoporosis	0.0162	0.0168	CcSEcCtD
Desonide—Application site reaction—Estradiol—osteoporosis	0.0131	0.0136	CcSEcCtD
Desonide—Blood pressure increased—Estropipate—osteoporosis	0.0116	0.0121	CcSEcCtD
Desonide—Blood pressure increased—Raloxifene—osteoporosis	0.0113	0.0117	CcSEcCtD
Desonide—Blood pressure increased—Ethinyl Estradiol—osteoporosis	0.00944	0.00979	CcSEcCtD
Desonide—Asthma—Etidronic acid—osteoporosis	0.00844	0.00876	CcSEcCtD
Desonide—Irritability—Estropipate—osteoporosis	0.00807	0.00837	CcSEcCtD
Desonide—Blood pressure increased—Conjugated Estrogens—osteoporosis	0.00769	0.00798	CcSEcCtD
Desonide—Asthma—Estropipate—osteoporosis	0.0073	0.00757	CcSEcCtD
Desonide—Asthma—Alendronate—osteoporosis	0.00719	0.00746	CcSEcCtD
Desonide—Asthma—Ibandronate—osteoporosis	0.007	0.00726	CcSEcCtD
Desonide—Viral infection—Estradiol—osteoporosis	0.00682	0.00707	CcSEcCtD
Desonide—Upper respiratory tract infection—Estropipate—osteoporosis	0.00679	0.00704	CcSEcCtD
Desonide—Hyperglycaemia—Estropipate—osteoporosis	0.00659	0.00683	CcSEcCtD
Desonide—Irritability—Ethinyl Estradiol—osteoporosis	0.00654	0.00678	CcSEcCtD
Desonide—Infestation NOS—Estropipate—osteoporosis	0.00651	0.00675	CcSEcCtD
Desonide—Infestation—Estropipate—osteoporosis	0.00651	0.00675	CcSEcCtD
Desonide—Upper respiratory tract infection—Ibandronate—osteoporosis	0.00651	0.00675	CcSEcCtD
Desonide—Pain—Calcium Acetate—osteoporosis	0.00625	0.00649	CcSEcCtD
Desonide—Infestation NOS—Ibandronate—osteoporosis	0.00625	0.00648	CcSEcCtD
Desonide—Infestation—Ibandronate—osteoporosis	0.00625	0.00648	CcSEcCtD
Desonide—Testolactone—CYP19A1—osteoporosis	0.00617	0.491	CrCbGaD
Desonide—Blood pressure increased—Estradiol—osteoporosis	0.00616	0.00639	CcSEcCtD
Desonide—Dermatitis contact—Estradiol—osteoporosis	0.00609	0.00631	CcSEcCtD
Desonide—Sweating—Raloxifene—osteoporosis	0.00605	0.00627	CcSEcCtD
Desonide—Sweating—Ibandronate—osteoporosis	0.00599	0.00621	CcSEcCtD
Desonide—Erythema—Etidronic acid—osteoporosis	0.00588	0.0061	CcSEcCtD
Desonide—Skin exfoliation—Estradiol—osteoporosis	0.00588	0.0061	CcSEcCtD
Desonide—Pharyngitis—Estropipate—osteoporosis	0.0058	0.00602	CcSEcCtD
Desonide—Asthma—Risedronate—osteoporosis	0.00577	0.00599	CcSEcCtD
Desonide—Oedema peripheral—Estropipate—osteoporosis	0.00576	0.00597	CcSEcCtD
Desonide—Oedema peripheral—Alendronate—osteoporosis	0.00567	0.00588	CcSEcCtD
Desonide—Pharyngitis—Raloxifene—osteoporosis	0.00562	0.00583	CcSEcCtD
Desonide—Oedema peripheral—Raloxifene—osteoporosis	0.00558	0.00579	CcSEcCtD
Desonide—Pharyngitis—Ibandronate—osteoporosis	0.00556	0.00577	CcSEcCtD
Desonide—Pain—Ergocalciferol—osteoporosis	0.00552	0.00573	CcSEcCtD
Desonide—Oedema peripheral—Ibandronate—osteoporosis	0.00552	0.00573	CcSEcCtD
Desonide—Upper respiratory tract infection—Ethinyl Estradiol—osteoporosis	0.0055	0.00571	CcSEcCtD
Desonide—Upper respiratory tract infection—Risedronate—osteoporosis	0.00537	0.00556	CcSEcCtD
Desonide—Irritability—Conjugated Estrogens—osteoporosis	0.00533	0.00553	CcSEcCtD
Desonide—Infestation—Ethinyl Estradiol—osteoporosis	0.00528	0.00547	CcSEcCtD
Desonide—Infestation NOS—Ethinyl Estradiol—osteoporosis	0.00528	0.00547	CcSEcCtD
Desonide—Mediastinal disorder—Estropipate—osteoporosis	0.00527	0.00546	CcSEcCtD
Desonide—Pruritus—Calcium Acetate—osteoporosis	0.00517	0.00537	CcSEcCtD
Desonide—Infestation NOS—Risedronate—osteoporosis	0.00515	0.00534	CcSEcCtD
Desonide—Infestation—Risedronate—osteoporosis	0.00515	0.00534	CcSEcCtD
Desonide—Mental disorder—Estropipate—osteoporosis	0.00512	0.00531	CcSEcCtD
Desonide—Upper respiratory tract infection—Pamidronate—osteoporosis	0.0051	0.00529	CcSEcCtD
Desonide—Erythema—Estropipate—osteoporosis	0.00509	0.00528	CcSEcCtD
Desonide—Mediastinal disorder—Ibandronate—osteoporosis	0.00505	0.00524	CcSEcCtD
Desonide—Erythema—Alendronate—osteoporosis	0.00501	0.0052	CcSEcCtD
Desonide—Asthma—Zoledronate—osteoporosis	0.00501	0.0052	CcSEcCtD
Desonide—Mental disorder—Ibandronate—osteoporosis	0.00491	0.00509	CcSEcCtD
Desonide—Infestation NOS—Pamidronate—osteoporosis	0.00489	0.00507	CcSEcCtD
Desonide—Infestation—Pamidronate—osteoporosis	0.00489	0.00507	CcSEcCtD
Desonide—Erythema—Ibandronate—osteoporosis	0.00488	0.00506	CcSEcCtD
Desonide—Asthma—Conjugated Estrogens—osteoporosis	0.00483	0.00501	CcSEcCtD
Desonide—Erythema—Calcitriol—osteoporosis	0.00478	0.00495	CcSEcCtD
Desonide—Infection—Etidronic acid—osteoporosis	0.00477	0.00495	CcSEcCtD
Desonide—Pharyngitis—Ethinyl Estradiol—osteoporosis	0.0047	0.00488	CcSEcCtD
Desonide—Upper respiratory tract infection—Zoledronate—osteoporosis	0.00466	0.00483	CcSEcCtD
Desonide—Pharyngitis—Risedronate—osteoporosis	0.00459	0.00476	CcSEcCtD
Desonide—Oedema peripheral—Risedronate—osteoporosis	0.00455	0.00472	CcSEcCtD
Desonide—Upper respiratory tract infection—Conjugated Estrogens—osteoporosis	0.00449	0.00465	CcSEcCtD
Desonide—Infestation NOS—Zoledronate—osteoporosis	0.00447	0.00463	CcSEcCtD
Desonide—Infestation—Zoledronate—osteoporosis	0.00447	0.00463	CcSEcCtD
Desonide—Cough—Estropipate—osteoporosis	0.00444	0.00461	CcSEcCtD
Desonide—Hyperglycaemia—Conjugated Estrogens—osteoporosis	0.00435	0.00451	CcSEcCtD
Desonide—Infestation NOS—Conjugated Estrogens—osteoporosis	0.0043	0.00446	CcSEcCtD
Desonide—Infestation—Conjugated Estrogens—osteoporosis	0.0043	0.00446	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.0043	0.00446	CcSEcCtD
Desonide—Cough—Raloxifene—osteoporosis	0.0043	0.00446	CcSEcCtD
Desonide—Irritability—Estradiol—osteoporosis	0.00427	0.00442	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.00417	0.00432	CcSEcCtD
Desonide—Mediastinal disorder—Risedronate—osteoporosis	0.00416	0.00432	CcSEcCtD
Desonide—Mental disorder—Ethinyl Estradiol—osteoporosis	0.00415	0.00431	CcSEcCtD
Desonide—Infection—Estropipate—osteoporosis	0.00413	0.00428	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.00413	0.00428	CcSEcCtD
Desonide—Nervous system disorder—Estropipate—osteoporosis	0.00407	0.00422	CcSEcCtD
Desonide—Infection—Alendronate—osteoporosis	0.00406	0.00421	CcSEcCtD
Desonide—Mental disorder—Risedronate—osteoporosis	0.00405	0.0042	CcSEcCtD
Desonide—Skin disorder—Estropipate—osteoporosis	0.00403	0.00418	CcSEcCtD
Desonide—Infection—Raloxifene—osteoporosis	0.004	0.00415	CcSEcCtD
Desonide—Mediastinal disorder—Pamidronate—osteoporosis	0.00396	0.00411	CcSEcCtD
Desonide—Infection—Ibandronate—osteoporosis	0.00396	0.0041	CcSEcCtD
Desonide—Oedema peripheral—Zoledronate—osteoporosis	0.00395	0.0041	CcSEcCtD
Desonide—Nervous system disorder—Raloxifene—osteoporosis	0.00395	0.00409	CcSEcCtD
Desonide—Skin disorder—Raloxifene—osteoporosis	0.00391	0.00405	CcSEcCtD
Desonide—Nervous system disorder—Ibandronate—osteoporosis	0.00391	0.00405	CcSEcCtD
Desonide—Hyperhidrosis—Raloxifene—osteoporosis	0.00389	0.00403	CcSEcCtD
Desonide—Skin disorder—Ibandronate—osteoporosis	0.00387	0.00401	CcSEcCtD
Desonide—Asthma—Estradiol—osteoporosis	0.00386	0.00401	CcSEcCtD
Desonide—Hyperhidrosis—Ibandronate—osteoporosis	0.00385	0.00399	CcSEcCtD
Desonide—Pharyngitis—Conjugated Estrogens—osteoporosis	0.00383	0.00398	CcSEcCtD
Desonide—Erythema—Pamidronate—osteoporosis	0.00382	0.00397	CcSEcCtD
Desonide—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.00381	0.00395	CcSEcCtD
Desonide—Skin disorder—Calcitriol—osteoporosis	0.00379	0.00393	CcSEcCtD
Desonide—Mediastinal disorder—Zoledronate—osteoporosis	0.00362	0.00375	CcSEcCtD
Desonide—Cough—Ethinyl Estradiol—osteoporosis	0.0036	0.00373	CcSEcCtD
Desonide—Upper respiratory tract infection—Estradiol—osteoporosis	0.00359	0.00372	CcSEcCtD
Desonide—Pain—Estropipate—osteoporosis	0.00355	0.00368	CcSEcCtD
Desonide—Mental disorder—Zoledronate—osteoporosis	0.00352	0.00365	CcSEcCtD
Desonide—Cough—Risedronate—osteoporosis	0.00351	0.00364	CcSEcCtD
Desonide—Pain—Alendronate—osteoporosis	0.0035	0.00363	CcSEcCtD
Desonide—Erythema—Zoledronate—osteoporosis	0.00349	0.00362	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.00349	0.00362	CcSEcCtD
Desonide—Hyperglycaemia—Estradiol—osteoporosis	0.00348	0.00361	CcSEcCtD
Desonide—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.00348	0.00361	CcSEcCtD
Desonide—Infestation—Estradiol—osteoporosis	0.00344	0.00357	CcSEcCtD
Desonide—Infestation NOS—Estradiol—osteoporosis	0.00344	0.00357	CcSEcCtD
Desonide—Pain—Raloxifene—osteoporosis	0.00344	0.00357	CcSEcCtD
Desonide—Pain—Ibandronate—osteoporosis	0.00341	0.00353	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.0034	0.00353	CcSEcCtD
Desonide—Pruritus—Etidronic acid—osteoporosis	0.0034	0.00352	CcSEcCtD
Desonide—Mental disorder—Conjugated Estrogens—osteoporosis	0.00338	0.00351	CcSEcCtD
Desonide—Erythema—Conjugated Estrogens—osteoporosis	0.00336	0.00349	CcSEcCtD
Desonide—Infection—Ethinyl Estradiol—osteoporosis	0.00335	0.00347	CcSEcCtD
Desonide—Cough—Pamidronate—osteoporosis	0.00334	0.00346	CcSEcCtD
Desonide—Pain—Calcitriol—osteoporosis	0.00333	0.00346	CcSEcCtD
Desonide—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.0033	0.00342	CcSEcCtD
Desonide—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00327	0.00339	CcSEcCtD
Desonide—Infection—Risedronate—osteoporosis	0.00326	0.00338	CcSEcCtD
Desonide—Nervous system disorder—Risedronate—osteoporosis	0.00322	0.00334	CcSEcCtD
Desonide—Skin disorder—Risedronate—osteoporosis	0.00319	0.00331	CcSEcCtD
Desonide—Infection—Pamidronate—osteoporosis	0.0031	0.00321	CcSEcCtD
Desonide—Pharyngitis—Estradiol—osteoporosis	0.00307	0.00318	CcSEcCtD
Desonide—Nervous system disorder—Pamidronate—osteoporosis	0.00306	0.00317	CcSEcCtD
Desonide—Cough—Zoledronate—osteoporosis	0.00305	0.00316	CcSEcCtD
Desonide—Oedema peripheral—Estradiol—osteoporosis	0.00305	0.00316	CcSEcCtD
Desonide—Rash—Etidronic acid—osteoporosis	0.00303	0.00314	CcSEcCtD
Desonide—Dermatitis—Etidronic acid—osteoporosis	0.00302	0.00314	CcSEcCtD
Desonide—Hyperhidrosis—Pamidronate—osteoporosis	0.00302	0.00313	CcSEcCtD
Desonide—Headache—Etidronic acid—osteoporosis	0.00301	0.00312	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00295	0.00306	CcSEcCtD
Desonide—Pruritus—Estropipate—osteoporosis	0.00294	0.00305	CcSEcCtD
Desonide—Cough—Conjugated Estrogens—osteoporosis	0.00293	0.00304	CcSEcCtD
Desonide—Pruritus—Alendronate—osteoporosis	0.00289	0.003	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00284	0.00295	CcSEcCtD
Desonide—Infection—Zoledronate—osteoporosis	0.00283	0.00294	CcSEcCtD
Desonide—Pruritus—Ibandronate—osteoporosis	0.00282	0.00292	CcSEcCtD
Desonide—Pain—Risedronate—osteoporosis	0.00281	0.00291	CcSEcCtD
Desonide—Nervous system disorder—Zoledronate—osteoporosis	0.0028	0.0029	CcSEcCtD
Desonide—Mediastinal disorder—Estradiol—osteoporosis	0.00279	0.00289	CcSEcCtD
Desonide—Skin disorder—Zoledronate—osteoporosis	0.00277	0.00287	CcSEcCtD
Desonide—Pruritus—Calcitriol—osteoporosis	0.00276	0.00286	CcSEcCtD
Desonide—Hyperhidrosis—Zoledronate—osteoporosis	0.00276	0.00286	CcSEcCtD
Desonide—Infection—Conjugated Estrogens—osteoporosis	0.00273	0.00283	CcSEcCtD
Desonide—Mental disorder—Estradiol—osteoporosis	0.00271	0.00281	CcSEcCtD
Desonide—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00269	0.00279	CcSEcCtD
Desonide—Erythema—Estradiol—osteoporosis	0.00269	0.00279	CcSEcCtD
Desonide—Pain—Pamidronate—osteoporosis	0.00267	0.00277	CcSEcCtD
Desonide—Skin disorder—Conjugated Estrogens—osteoporosis	0.00267	0.00276	CcSEcCtD
Desonide—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00265	0.00275	CcSEcCtD
Desonide—Rash—Estropipate—osteoporosis	0.00262	0.00272	CcSEcCtD
Desonide—Dermatitis—Estropipate—osteoporosis	0.00262	0.00271	CcSEcCtD
Desonide—Headache—Estropipate—osteoporosis	0.0026	0.0027	CcSEcCtD
Desonide—Rash—Alendronate—osteoporosis	0.00258	0.00268	CcSEcCtD
Desonide—Dermatitis—Alendronate—osteoporosis	0.00258	0.00267	CcSEcCtD
Desonide—Hydrocortisone—SHBG—osteoporosis	0.00258	0.205	CrCbGaD
Desonide—Headache—Alendronate—osteoporosis	0.00256	0.00266	CcSEcCtD
Desonide—Rash—Raloxifene—osteoporosis	0.00254	0.00263	CcSEcCtD
Desonide—Dermatitis—Raloxifene—osteoporosis	0.00253	0.00263	CcSEcCtD
Desonide—Headache—Raloxifene—osteoporosis	0.00252	0.00261	CcSEcCtD
Desonide—Rash—Ibandronate—osteoporosis	0.00251	0.0026	CcSEcCtD
Desonide—Dermatitis—Ibandronate—osteoporosis	0.00251	0.0026	CcSEcCtD
Desonide—Headache—Ibandronate—osteoporosis	0.0025	0.00259	CcSEcCtD
Desonide—Rash—Calcitriol—osteoporosis	0.00246	0.00255	CcSEcCtD
Desonide—Dermatitis—Calcitriol—osteoporosis	0.00246	0.00255	CcSEcCtD
Desonide—Headache—Calcitriol—osteoporosis	0.00244	0.00253	CcSEcCtD
Desonide—Pain—Zoledronate—osteoporosis	0.00244	0.00253	CcSEcCtD
Desonide—Betamethasone—CYP19A1—osteoporosis	0.00242	0.192	CrCbGaD
Desonide—Pruritus—Ethinyl Estradiol—osteoporosis	0.00238	0.00247	CcSEcCtD
Desonide—Cough—Estradiol—osteoporosis	0.00235	0.00244	CcSEcCtD
Desonide—Pain—Conjugated Estrogens—osteoporosis	0.00235	0.00243	CcSEcCtD
Desonide—Pruritus—Risedronate—osteoporosis	0.00232	0.00241	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00228	0.00236	CcSEcCtD
Desonide—Pruritus—Pamidronate—osteoporosis	0.00221	0.00229	CcSEcCtD
Desonide—Infection—Estradiol—osteoporosis	0.00218	0.00226	CcSEcCtD
Desonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—RAP1A—osteoporosis	0.00218	0.0947	CbGpPWpGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—TUBA1B—osteoporosis	0.00216	0.0939	CbGpPWpGaD
Desonide—Nervous system disorder—Estradiol—osteoporosis	0.00215	0.00223	CcSEcCtD
Desonide—Skin disorder—Estradiol—osteoporosis	0.00213	0.00221	CcSEcCtD
Desonide—Hyperhidrosis—Estradiol—osteoporosis	0.00212	0.0022	CcSEcCtD
Desonide—Rash—Ethinyl Estradiol—osteoporosis	0.00212	0.0022	CcSEcCtD
Desonide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00212	0.0022	CcSEcCtD
Desonide—Headache—Ethinyl Estradiol—osteoporosis	0.00211	0.00219	CcSEcCtD
Desonide—Rash—Risedronate—osteoporosis	0.00207	0.00215	CcSEcCtD
Desonide—Dermatitis—Risedronate—osteoporosis	0.00207	0.00214	CcSEcCtD
Desonide—Headache—Risedronate—osteoporosis	0.00206	0.00213	CcSEcCtD
Desonide—Pruritus—Zoledronate—osteoporosis	0.00202	0.00209	CcSEcCtD
Desonide—Rash—Pamidronate—osteoporosis	0.00197	0.00204	CcSEcCtD
Desonide—Dermatitis—Pamidronate—osteoporosis	0.00197	0.00204	CcSEcCtD
Desonide—Headache—Pamidronate—osteoporosis	0.00196	0.00203	CcSEcCtD
Desonide—Pruritus—Conjugated Estrogens—osteoporosis	0.00194	0.00201	CcSEcCtD
Desonide—Pain—Estradiol—osteoporosis	0.00188	0.00195	CcSEcCtD
Desonide—Rash—Zoledronate—osteoporosis	0.0018	0.00186	CcSEcCtD
Desonide—Dermatitis—Zoledronate—osteoporosis	0.0018	0.00186	CcSEcCtD
Desonide—Headache—Zoledronate—osteoporosis	0.00179	0.00185	CcSEcCtD
Desonide—Rash—Conjugated Estrogens—osteoporosis	0.00173	0.00179	CcSEcCtD
Desonide—Dermatitis—Conjugated Estrogens—osteoporosis	0.00173	0.00179	CcSEcCtD
Desonide—Headache—Conjugated Estrogens—osteoporosis	0.00172	0.00178	CcSEcCtD
Desonide—Pruritus—Estradiol—osteoporosis	0.00155	0.00161	CcSEcCtD
Desonide—Dexamethasone—CYP19A1—osteoporosis	0.00141	0.112	CrCbGaD
Desonide—Rash—Estradiol—osteoporosis	0.00139	0.00144	CcSEcCtD
Desonide—Dermatitis—Estradiol—osteoporosis	0.00138	0.00143	CcSEcCtD
Desonide—Headache—Estradiol—osteoporosis	0.00138	0.00143	CcSEcCtD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—IRS2—osteoporosis	0.000896	0.0389	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptors—ESR2—osteoporosis	0.000892	0.0387	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—osteoporosis	0.000877	0.0381	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—COL1A2—osteoporosis	0.000789	0.0342	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—IRS1—osteoporosis	0.000783	0.034	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—DKK1—osteoporosis	0.000761	0.033	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—NFATC1—osteoporosis	0.00075	0.0325	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptors—VDR—osteoporosis	0.000708	0.0307	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.000705	0.0306	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	0.000702	0.0305	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—PTHLH—osteoporosis	0.000663	0.0288	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—NFATC1—osteoporosis	0.000661	0.0287	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—osteoporosis	0.000602	0.0261	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.000559	0.0243	CbGpPWpGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—osteoporosis	0.000541	0.0235	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptors—ESR1—osteoporosis	0.000541	0.0235	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—WNT1—osteoporosis	0.000437	0.0189	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.000427	0.0185	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.000416	0.018	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—osteoporosis	0.000406	0.0176	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—BMP2—osteoporosis	0.000395	0.0171	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	0.000386	0.0168	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—ESR1—osteoporosis	0.000332	0.0144	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—osteoporosis	0.000327	0.0142	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoporosis	0.000295	0.0128	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.000288	0.0125	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—osteoporosis	0.000263	0.0114	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—IRS2—osteoporosis	0.000216	0.00939	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—LEP—osteoporosis	0.000212	0.00919	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—IRS1—osteoporosis	0.000189	0.0082	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—TGFB1—osteoporosis	0.000176	0.00764	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—IGF1—osteoporosis	0.000175	0.00759	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—MYC—osteoporosis	0.000173	0.00749	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—TGFB1—osteoporosis	0.000172	0.00747	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	0.000154	0.00666	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000153	0.00665	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—U2AF1—osteoporosis	0.000153	0.00664	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—IL6—osteoporosis	0.00013	0.00563	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—ESR2—osteoporosis	0.000122	0.00528	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.000117	0.00506	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—osteoporosis	0.000114	0.00496	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—RPL24—osteoporosis	0.000114	0.00493	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—TGFB1—osteoporosis	0.000105	0.00455	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—TNF—osteoporosis	9.8e-05	0.00425	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—VDR—osteoporosis	9.66e-05	0.00419	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—TNF—osteoporosis	8.47e-05	0.00367	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—IL6—osteoporosis	7.91e-05	0.00343	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—ESR1—osteoporosis	7.38e-05	0.0032	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL6—osteoporosis	6.83e-05	0.00296	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—PSMA2—osteoporosis	6.56e-05	0.00285	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—PSMA5—osteoporosis	6.56e-05	0.00285	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—ESR2—osteoporosis	5.86e-05	0.00254	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—VDR—osteoporosis	4.65e-05	0.00202	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—MYC—osteoporosis	3.84e-05	0.00167	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—ESR1—osteoporosis	3.55e-05	0.00154	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—MYC—osteoporosis	1.85e-05	0.000802	CbGpPWpGaD
